Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Industry: Healthcare

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Current Quote*
Last: $0.849
Change: -0.022
Book: $1.171
Volume: 250,073

As Of: 02/25 12:46 ET
*Quotes delayed by 20min.

Graphs for CTXR


3 Month Graph


6 Month Graph


1 Year Graph